Sacral chordoma is a rare low-to-intermediate grade malignant tumour. The mainstay of treatment is still surgery with en bloc and wide resection margins, which can grant the best chances of a long-term control or cure of this disease. The first aim of this paper is to collect data about survival, time to local recurrence and metastasis among patients affected by sacral chordoma and primarily treated with surgery. The second aim is to analyze the influence of level resection, tumor volume and surgical margins on local recurrence.
Surgical treatment of sacral chordoma: survival and prognostic factors / Ruosi, Carlo; Colella, Gianluca; DI DONATO, SIGISMONDO LUCA; Granata, Francesco; Di Salvatore, M. G; Fazioli, Flavio. - In: EUROPEAN SPINE JOURNAL. - ISSN 0940-6719. - 24 Suppl 7:S7(2015), pp. 912-7-917. [10.1007/s00586-015-4276-4]
Surgical treatment of sacral chordoma: survival and prognostic factors
RUOSI, CARLO;COLELLA, GIANLUCA;DI DONATO, SIGISMONDO LUCA;GRANATA, FRANCESCO;FAZIOLI, FLAVIO
2015
Abstract
Sacral chordoma is a rare low-to-intermediate grade malignant tumour. The mainstay of treatment is still surgery with en bloc and wide resection margins, which can grant the best chances of a long-term control or cure of this disease. The first aim of this paper is to collect data about survival, time to local recurrence and metastasis among patients affected by sacral chordoma and primarily treated with surgery. The second aim is to analyze the influence of level resection, tumor volume and surgical margins on local recurrence.File | Dimensione | Formato | |
---|---|---|---|
ARTICOLO PUBBLICATO 10.1007_s00586-015-4276-4.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
938.61 kB
Formato
Adobe PDF
|
938.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.